Invention Grant
US08415385B2 Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
有权
Sydnonimines特异性多巴胺再摄取抑制剂及其在治疗多巴胺相关疾病中的应用
- Patent Title: Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
- Patent Title (中): Sydnonimines特异性多巴胺再摄取抑制剂及其在治疗多巴胺相关疾病中的应用
-
Application No.: US13180996Application Date: 2011-07-12
-
Publication No.: US08415385B2Publication Date: 2013-04-09
- Inventor: Hao Chen , Ming Liu , Qi Su , Manish Raisinghani
- Applicant: Hao Chen , Ming Liu , Qi Su , Manish Raisinghani
- Agency: Dann, Dorfman, Herrell and Skillman, P.C.
- Agent Thomas H. Walls
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D271/04
Abstract:
Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
Public/Granted literature
- US20110288137A1 SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AD THEIR USE IN TREATING DOPAMINE RELATED DISORDERS Public/Granted day:2011-11-24
Information query
